LISATA THERAPEUTICS, INC.: net inventory
Net inventory for LISATA THERAPEUTICS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All LISATA THERAPEUTICS, INC. financial histories
What this measure means
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
Exact concept: us-gaap:InventoryNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-12-31 to 2013-12-31. The SEC response was captured on 2026-09-19.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2013-12-31 | 1,270,223 | USD | 2014-03-13 | 10-K · 0000320017-14-000007 |
| At date | 2012-12-31 | 1,113,025 | USD | 2014-03-13 | 10-K · 0000320017-14-000007 |
| At date | 2011-12-31 | 647,745 | USD | 2013-03-11 | 10-K · 0000320017-13-000009 |
| At date | 2010-12-31 | 21,023,388 | USD | 2012-03-20 | 10-K · 0001144204-12-016037 |
Related financial histories
- LISATA THERAPEUTICS, INC.: total assets
- LISATA THERAPEUTICS, INC.: total liabilities
- LISATA THERAPEUTICS, INC.: stockholders equity
- LISATA THERAPEUTICS, INC.: cash and cash equivalents
- LISATA THERAPEUTICS, INC.: net income or loss
- LISATA THERAPEUTICS, INC.: operating cash flow
- LISATA THERAPEUTICS, INC.: capital expenditure payments
- LISATA THERAPEUTICS, INC.: revenue
- LISATA THERAPEUTICS, INC.: contract revenue excluding tax
- LISATA THERAPEUTICS, INC.: financing cash flow
- LISATA THERAPEUTICS, INC.: investing cash flow
- LISATA THERAPEUTICS, INC.: retained earnings or deficit
- LISATA THERAPEUTICS, INC.: basic weighted-average shares
- LISATA THERAPEUTICS, INC.: diluted weighted-average shares
- LISATA THERAPEUTICS, INC.: basic earnings per share
- LISATA THERAPEUTICS, INC.: diluted earnings per share
- LISATA THERAPEUTICS, INC.: income tax expense or benefit
- LISATA THERAPEUTICS, INC.: net property, plant and equipment
- LISATA THERAPEUTICS, INC.: share-based compensation expense
- LISATA THERAPEUTICS, INC.: operating income or loss
- LISATA THERAPEUTICS, INC.: current assets
- LISATA THERAPEUTICS, INC.: interest expense
- LISATA THERAPEUTICS, INC.: current liabilities
- LISATA THERAPEUTICS, INC.: current accounts payable
- LISATA THERAPEUTICS, INC.: goodwill carrying amount
- LISATA THERAPEUTICS, INC.: net finite-lived intangible assets
- LISATA THERAPEUTICS, INC.: net current accounts receivable
- LISATA THERAPEUTICS, INC.: operating expenses
- LISATA THERAPEUTICS, INC.: gross profit
- LISATA THERAPEUTICS, INC.: cost of revenue
- LISATA THERAPEUTICS, INC.: selling, general and administrative expense
- LISATA THERAPEUTICS, INC.: research and development expense
Inspect the source
- Entity
- LISATA THERAPEUTICS, INC. / CIK 0000320017
- Captured
- 2026-09-19T14:56:51.274Z
- SEC response SHA-256
cea21c045f03a86f28b8ca2c2ed8647182755ec7b9afe40200702f5307c095db
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000320017.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))